HK1152877A1 - 可給予組合物 - Google Patents

可給予組合物

Info

Publication number
HK1152877A1
HK1152877A1 HK11106989.7A HK11106989A HK1152877A1 HK 1152877 A1 HK1152877 A1 HK 1152877A1 HK 11106989 A HK11106989 A HK 11106989A HK 1152877 A1 HK1152877 A1 HK 1152877A1
Authority
HK
Hong Kong
Prior art keywords
administrable compositions
administrable
compositions
Prior art date
Application number
HK11106989.7A
Other languages
English (en)
Inventor
Brian Stanley Hawkett
Nirmesh Jain
Thi Thuy Binh Pham
Yanjun Wang
Gregory Goodman Warr
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008902427A external-priority patent/AU2008902427A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Publication of HK1152877A1 publication Critical patent/HK1152877A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0404X-ray contrast preparations containing barium sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414Particles, beads, capsules or spheres
    • A61K49/0419Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11106989.7A 2008-05-16 2011-07-07 可給予組合物 HK1152877A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008902427A AU2008902427A0 (en) 2008-05-16 Administrable dispersions
AU2008904892A AU2008904892A0 (en) 2008-09-19 Further administrable dispersions
PCT/AU2009/000620 WO2009137890A1 (en) 2008-05-16 2009-05-15 Administrable compositions

Publications (1)

Publication Number Publication Date
HK1152877A1 true HK1152877A1 (zh) 2012-03-16

Family

ID=41318295

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11106989.7A HK1152877A1 (zh) 2008-05-16 2011-07-07 可給予組合物

Country Status (14)

Country Link
US (1) US8709486B2 (zh)
EP (1) EP2291175B1 (zh)
JP (1) JP5663472B2 (zh)
KR (1) KR101638201B1 (zh)
CN (1) CN102099010B (zh)
AU (1) AU2009246066B2 (zh)
CA (1) CA2724004C (zh)
DK (1) DK2291175T3 (zh)
ES (1) ES2519476T3 (zh)
HK (1) HK1152877A1 (zh)
IL (1) IL209243A (zh)
NZ (1) NZ589287A (zh)
PT (1) PT2291175E (zh)
WO (1) WO2009137890A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2833413C (en) * 2011-04-20 2020-09-22 The University Of Sydney A method for the treatment of a solid tumour
BE1026147B1 (nl) * 2018-03-29 2019-10-28 Farm@Nutrition Besloten Vennootschap Met Beperkte Aansprakelijkheid Samenstelling voor een voedingsadditief voor dieren en werkwijze om het additief toe te dienen.
CA3158357A1 (en) * 2019-11-21 2021-05-27 Ferronova Pty Ltd Magnetic tracer compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736262A (en) 1969-01-28 1973-05-29 O Pirtle Colloidal composition useful as vehicle for diagnostic radioisotopes
US4772407A (en) * 1987-12-02 1988-09-20 Lord Corporation Electrorheological fluids
DE4117782C2 (de) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
FR2824563B1 (fr) 2001-05-10 2004-12-03 Bio Merieux Particules composites, conjugues derives, procede de preparation et applications
US7094810B2 (en) * 2001-06-08 2006-08-22 Labopharm, Inc. pH-sensitive block copolymers for pharmaceutical compositions
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US7820737B2 (en) 2003-03-13 2010-10-26 Eugenia Kumacheva Method of producing hybrid polymer-inorganic materials
US20050266394A1 (en) 2003-12-24 2005-12-01 Massachusette Institute Of Technology Magnetophoretic cell clarification
JP2006328309A (ja) * 2005-05-30 2006-12-07 Canon Inc 磁性ポリマー粒子及びその製造方法
US20070264199A1 (en) * 2005-09-26 2007-11-15 Labhasetwar Vinod D Magnetic nanoparticle composition and methods for using the same
KR100819378B1 (ko) 2006-02-24 2008-04-04 (주)에이티젠 양친매성 화합물을 이용한 자성 나노복합체 및 이를포함하는 약제학적 조성물
CA2643596A1 (en) * 2006-04-03 2007-10-11 The University Of Sydney Polymer product and interfacial polymerisation process using raft agent

Also Published As

Publication number Publication date
WO2009137890A1 (en) 2009-11-19
US20110129417A1 (en) 2011-06-02
JP5663472B2 (ja) 2015-02-04
NZ589287A (en) 2012-06-29
CA2724004C (en) 2016-08-23
AU2009246066B2 (en) 2014-03-06
ES2519476T3 (es) 2014-11-07
IL209243A (en) 2015-11-30
PT2291175E (pt) 2014-11-04
IL209243A0 (en) 2011-01-31
CN102099010A (zh) 2011-06-15
EP2291175A4 (en) 2013-04-03
CN102099010B (zh) 2016-09-14
US8709486B2 (en) 2014-04-29
KR101638201B1 (ko) 2016-07-08
AU2009246066A1 (en) 2009-11-19
EP2291175A1 (en) 2011-03-09
CA2724004A1 (en) 2009-11-19
DK2291175T3 (da) 2014-11-03
EP2291175B1 (en) 2014-07-23
JP2011520816A (ja) 2011-07-21
KR20110025759A (ko) 2011-03-11

Similar Documents

Publication Publication Date Title
PL2634231T3 (pl) Kompozycje
GB0810404D0 (en) Compositions
IL217949A0 (en) Pesticdal compositions
EP2488022A4 (en) Compositions
ZA201109176B (en) Homeglobin compositions
ZA201103926B (en) Stable sulfoximine-insecticide compositions
EP2219637A4 (en) AVENANTHRAMIDE COMPOSITIONS
GB0906515D0 (en) Fungical compositions
HK1159668A1 (en) Multi-cure compositions
GB0812041D0 (en) Compositions
GB0808537D0 (en) Compositions
GB0818804D0 (en) Compositions
ZA201109312B (en) Compositions
EP2485807A4 (en) SUN PROTECTION COMPOSITIONS
GB0905165D0 (en) Compositions
HK1152877A1 (zh) 可給予組合物
EP2259934A4 (en) NEW MIKTOPOLYMERIC COMPOSITIONS
EP2214697A4 (en) COMPOSITIONS OF NELL-1
EP2475712A4 (en) INITIATOR REINFORCED COMPOSITIONS
GB0908963D0 (en) Compositions
AU2008902429A0 (en) Administrable compositions
GB0822112D0 (en) Compositions
GB0800412D0 (en) Compositions
GB0805099D0 (en) Claening compositions
GB0818050D0 (en) Compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180515